We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.

Search results

Order by: most recent most popular relevance



Results: 1-10 of 391

Another State Alleges False Claims Act Violation to Combat Opioid Crisis
  • McDermott Will & Emery
  • USA
  • October 26 2017

On October 5, 2017, the State of New Jersey sued Insys Therapeutics, Inc. (Insys), alleging that the company improperly marketed and promoted the


New Jersey Files Lawsuit Against Opioid Manufacturer
  • Stark & Stark
  • USA
  • October 26 2017

Attorney General Christopher S. Porrino recently announced that New Jersey has filed a lawsuit against Insys Therapeutics, Inc. charging that the


Insys Therapeutics Runs Afoul of Attorneys General in Two States
  • FisherBroyles LLP
  • USA
  • October 10 2017

Arizona-based pharmaceutical company Insys Therapeutics Inc. (Insys) has found itself under investigation in both Massachusetts and New Jersey over


New Evidence of Amputation Risk Impacts Invokana MDL
  • Stark & Stark
  • USA
  • October 5 2017

In July 2017, an FDA-mandated cardiovascular outcomes trial (CANVAS) reported that Invokana use roughly doubles the risk of lower limb amputation


Lawsuit Filed in Papaya Salmonella Outbreak
  • Shook Hardy & Bacon LLP
  • USA
  • July 28 2017

A New Jersey man has filed a lawsuit against a produce supplier for its role in a Salmonella Kiambu outbreak in 12 states linked to Mexican papayas


Defibrillator Device Suit Dismissed On Federal Preemption
  • Weil Gotshal & Manges LLP
  • USA
  • May 22 2017

A District Court in New Jersey recently dismissed a products liability action against Boston Scientific Corp., Guidant Corp., and two related medical


Dietary Supplement & Cosmetics Legal Bulletin: March 2017
  • Shook Hardy & Bacon LLP
  • USA
  • March 31 2017

FDA Warning Letters on the Rise. Nearly 30 warning letters were issued by the U.S. Food and Drug Administration (FDA) regarding


FDA-Approved Labeling Medical Standard Of Care
  • Reed Smith LLP
  • USA
  • February 13 2017

We’ve been defending the ability of physicians to engage in off-label use ever since the Bone Screw litigation of the 1990s. Buckman Co. v


Legislation Easing The Registration Process For Pharmaceutical Companies Enacted In New Jersey
  • Porzio Bromberg & Newman PC
  • USA
  • December 5 2016

Porzio is pleased to announce that Porzio-supported legislation was signed into law by New Jersey Governor Chris Christie. As a result, product


New Jersey Accutane Plaintiff Verdict Vacated - Appellate Division Strongly Criticizes Evidentiary Rulings
  • Dechert LLP
  • USA
  • July 26 2016

If you read the decision in Rossitto v. Hoffmann-LaRoche Inc., 2016 N.J. Super. Unpub. LEXIS 1714 (N.J. App. Div. Jul 22, 2016), we think you'll